Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study

Coombs, C. C., Woyach, J. A., Brown, J. R., Ghia, P., Roeker, L. E., Patel, K., Eyre, T. A., Tam, C. S., Seymour, J. F., Shah, N. N., Flinn, I. W., Cheah, C. Y., Ma, S., Rhodes, J. M., Izutsu, K., Jurczak, W., Wierda, W. G., Loubert, A., Payakachat, N., … Lamanna, N. (2023). Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study. Blood, 142(Supplement 1), 6535–6535. https://doi.org/10.1182/blood-2023-186145
Authors:
Catherine C. Coombs
Jennifer A. Woyach
Jennifer R. Brown
Paolo Ghia
Lindsey E. Roeker
Krish Patel
Toby A. Eyre
Constantine S. Tam
John F. Seymour
Nirav N. Shah
Ian W. Flinn
Chan Y. Cheah
Shuo Ma
Joanna Rhodes
Koji Izutsu
Wojciech Jurczak
William G. Wierda
Angély Loubert
Nalin Payakachat
Lisa M. Hess
Paolo Abada
Nicole Lamanna
Affiliated Authors:
Nicole Lamanna
Publication Type:
Article
Unique ID:
10.1182/blood-2023-186145
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: